![Mark Kelly](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Mark Kelly
Directeur Financier/CFO chez
CODA OCTOPUS GROUP, INC.
Profil
Mark Kelly is currently the Chief Financial Officer at Coda Octopus Group, Inc. since 2026.
Formerly, Mr. Kelly was the Finance Director at medac Pharma LLP from 2024 to 2025.
Mr. Kelly completed undergraduate studies at the University of Strathclyde.
Postes actifs de Mark Kelly
| Sociétés | Poste | Début |
|---|---|---|
| CODA OCTOPUS GROUP, INC. | Directeur Financier/CFO | 03/08/2026 |
Anciens postes connus de Mark Kelly
| Sociétés | Poste | Fin |
|---|---|---|
medac Pharma LLP
 medac Pharma LLP Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Directeur Financier/CFO | 01/01/2025 |
Formation de Mark Kelly
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
7
Relations au 1er degré
3
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Coda Octopus Group, Inc.
 Coda Octopus Group, Inc. Aerospace & DefenseElectronic Technology Engages in marine technology, defense engineering system and acoustics sensors and materials sectors | Electronic Technology |
University of Strathclyde
 University of Strathclyde Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
medac Pharma LLP
medac Pharma LLP Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
